Recent Finacing
Recent Raise
Outpost Medicine, based in Indianapolis and London, develops oral therapeutics for urologic and gastrointestinal disorders, focusing on OP-687 for OAB/IBS and a Takeda-licensed OP-233 for stress urinary incontinence.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors